Observatory · observe first
Pfizer
PFE · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
1.232%
12M weight contribution
+0.010 pp
3M weight contribution
-0.053 pp
12M price return
+23.5%
Share of matched S&P 500 members
Monthly observations through Jun 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Jun 2019 | $228.5bn | 1.232% | +0.010 pp | +23.5% | Yes |
| May 2019 | $219.0bn | 1.275% | +0.066 pp | +19.5% | Yes |
| Apr 2019 | $213.9bn | 1.192% | -0.079 pp | +14.8% | Yes |
| Mar 2019 | $223.7bn | 1.285% | +0.055 pp | +23.9% | Yes |
| Feb 2019 | $228.3bn | 1.324% | +0.095 pp | +23.6% | Yes |
| Jan 2019 | $232.8bn | 0.768% | -0.427 pp | +19.7% | No |
| Dec 2018 | $239.4bn | 0.856% | -0.339 pp | +22.1% | No |
| Nov 2018 | $253.5bn | 0.842% | -0.352 pp | +29.3% | No |
| Oct 2018 | $239.5bn | 0.812% | -0.383 pp | +19.5% | No |
| Sep 2018 | $245.1bn | 0.781% | -0.414 pp | +22.3% | No |
| Aug 2018 | $230.9bn | 0.745% | -0.449 pp | +15.2% | No |
| Jul 2018 | $221.6bn | 1.293% | +0.098 pp | +9.9% | Yes |
| Jun 2018 | $201.3bn | 1.222% | +0.027 pp | -0.2% | No |
| May 2018 | $199.4bn | 1.210% | +0.015 pp | -1.1% | No |
| Apr 2018 | $206.8bn | 1.271% | +0.076 pp | -0.2% | Yes |
| Mar 2018 | $200.4bn | 1.230% | +0.035 pp | -3.3% | Yes |
| Feb 2018 | $205.1bn | 1.229% | +0.034 pp | -1.1% | Yes |
| Jan 2018 | $209.5bn | 1.195% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.